New Delhi, India – [Current Date] – India’s burgeoning medical value tourism (MVT) sector has showcased remarkable resilience, reporting a significant increase in revenue during Financial Year 2026 (FY26), even as geopolitical tensions in West Asia and political instability in Bangladesh led to a noticeable decline in international patient volumes. This paradoxical growth underscores a strategic pivot by leading Indian hospital chains towards high-value, complex medical procedures, effectively offsetting the dip in overall patient footfalls with higher realisations per case.
The latest financial disclosures from listed hospital companies paint a compelling picture of adaptation and strategic foresight. Despite the challenging external environment, which saw a disruption in the inflow of international patients, particularly in March, the annual international business revenues remained robust, signaling a maturing and diversified approach within India’s healthcare landscape.
The Paradox: Revenue Growth Amidst Patient Volume Decline
At the heart of this seemingly contradictory trend lies a fundamental shift in the profile of medical tourists seeking treatment in India. While the total number of patients may have decreased from certain traditional markets, those who did travel were increasingly seeking highly specialized, advanced, and often life-saving procedures. This focus on complex tertiary and quaternary care, which commands higher costs, has effectively driven up average revenue per patient, leading to an overall increase in MVT revenues for the industry.
India has long been a global hub for medical tourism, renowned for its cost-effectiveness, world-class medical expertise, advanced technology, and accreditations comparable to Western standards. Patients from across the globe, particularly from developing nations in Africa, the Middle East, and South Asia, have historically flocked to India for treatments ranging from cardiology and orthopaedics to oncology and organ transplants. However, the events of FY26 presented an unprecedented test to this thriving sector, forcing a re-evaluation of strategies and market dependencies.
Geopolitical Turbulence and Its Immediate Impact
The year FY26 was marked by significant external pressures that directly impacted the flow of international patients into India. Two major geographical regions, West Asia and Bangladesh, which traditionally form the bedrock of India’s MVT market, experienced disruptions that led to a tangible slowdown in patient arrivals.
West Asia Conflict: Disruptions and Patient Flow Shifts
The onset of the West Asia conflict created immediate ripples across global travel and commerce, and India’s medical tourism sector was no exception. Flight disruptions, heightened security concerns, and general economic uncertainty in the region made travel to India challenging for many prospective patients.
Fortis Healthcare, one of India’s leading hospital chains, provided a clear illustration of this immediate impact. Anil Vinayak, Group Chief Operating Officer (COO) at Fortis Healthcare, noted, “During the initial period of the conflict, the hospital largely catered to patients who had already travelled and were present in India. As a result, the business recorded a drop of around 7 per cent for the month [March].” This temporary decline underscored the vulnerability of patient inflows to external shocks, particularly those affecting air travel and regional stability.
Patients from West Asia predominantly rely on Indian hospitals for critical interventions such as heart surgeries, complex oncology procedures, organ transplants, and advanced orthopaedic treatments. The conflict not only made it difficult for new patients to travel but also posed logistical challenges for those requiring follow-up care or scheduled surgeries. The immediate response from hospitals was to prioritize and support patients already within India, ensuring continuity of care amidst the uncertainty. This period highlighted the critical need for hospitals to build robust support systems for international patients, including accommodation, local transport, and communication channels, to mitigate the impact of unforeseen global events.
Bangladesh Unrest: A Major Market’s Downturn
Even more significant, in terms of sheer volume, was the decline in patient numbers from Bangladesh. Historically, Bangladesh has been an indispensable market for India’s medical tourism, primarily due to geographical proximity, cultural similarities, and more affordable healthcare options compared to many Western countries. Government data on foreign tourist arrivals until 2024 indicated that a staggering 75 per cent of tourists coming to India for medical treatment were from Bangladesh. This statistic alone underscores the profound impact of any disruption from this neighbouring nation.
However, bilateral issues between India and Bangladesh in 2025 led to a noticeable decline in these numbers. While the specific nature of these bilateral issues wasn’t detailed, such disruptions often involve stricter visa regulations, border closures, or political tensions that make cross-border travel less feasible or desirable. For Indian hospital chains, which had become heavily reliant on this consistent flow of patients, the downturn from Bangladesh necessitated an urgent re-evaluation of their market strategies and a proactive search for alternative patient sources. The drop-off from Bangladesh served as a stark reminder of the risks associated with over-reliance on a single market, no matter how robust it might seem.
Strategic Pivots: How Hospitals Countered the Downturn
Faced with these significant challenges, Indian hospital chains demonstrated remarkable agility and strategic acumen. Instead of succumbing to the pressures, they actively recalibrated their approaches, focusing on enhancing value, diversifying their market reach, and leveraging their inherent strengths.
The High-Value Shift: Boosting Realisations
The most critical strategic pivot was the concerted effort to attract patients seeking complex, high-end medical procedures. While the overall patient volume from traditional markets might have dipped, the revenue figures soared, proving the efficacy of this strategy.
Fortis Healthcare, for instance, reported an impressive 18.5 per cent year-on-year (Y-o-Y) rise in MVT revenues, reaching ₹639 crore in FY26, up from ₹539 crore in FY25. This growth was not merely an anomaly; other large hospital chains, including Max Healthcare and Medanta, also reported strong growth in their international business during the year, driven by a similar focus.
This shift translates into a greater emphasis on advanced treatments such as robotic surgeries, organ transplants (kidney, liver, heart), complex oncology treatments (including radiation therapy and precision medicine), and highly specialized cardiac and neuro surgeries. These procedures typically involve longer hospital stays, more intensive care, and require state-of-the-art infrastructure and highly specialized medical teams, naturally leading to higher billing.
A Max Healthcare spokesperson elaborated on this strategy, stating that the chain delivered robust year-on-year growth in international patient revenues in FY26, "driven by a higher inflow of patients seeking complex, high-end tertiary and quaternary care treatments. This includes oncology, transplants and robotic surgeries, along with improved capacity utilisation and its new and modern infrastructure." This highlights the dual strategy of not only attracting high-value cases but also ensuring that the internal capacity and technology are in place to deliver such specialized care efficiently.
Patients choose India for these high-stakes procedures due to a compelling combination of factors: world-renowned specialists, advanced medical technology, significantly lower costs compared to Western countries (often 60-80% less), and a patient-centric approach that often includes language support and cultural understanding. For many, India offers a life-saving alternative that is financially viable without compromising on quality.
Diversifying the Global Footprint
The downturn in patient inflows from West Asia and Bangladesh served as a powerful impetus for Indian hospitals to accelerate their market diversification efforts. Market watchers noted that hospital chains have aggressively started expanding their footprint across new international markets while simultaneously reinforcing their presence in established regions.
Anil Vinayak of Fortis Healthcare confirmed this broader strategy, stating that the group "continues to receive international patients from diverse regions, including Africa, the Commonwealth of Independent States (CIS) countries, the Middle East, SAARC nations and Southeast Asia." He further noted the specific success stories within this diversification, highlighting that the "highest patient inflows within this footprint are from Iraq and Uzbekistan, along with strong contributions from East African countries such as Kenya, Tanzania, Ethiopia and Uganda." This strategic expansion into newer geographies like Central Asia and various parts of Africa is crucial for building a more resilient and geographically diversified patient base.
Apollo Hospitals, another major player, also demonstrated this adaptability. While the company did not share exact MVT revenue figures, its Managing Director Suneeta Reddy stated in an earnings call that Apollo’s strong FY26 performance came despite "lower seasonal medical admissions alongside moderation in international patient volumes, particularly from Bangladesh." This implies that Apollo successfully compensated for the dip from Bangladesh by increasing its share of patients from other regions such as Africa, West Asia, and Southeast Asia.
To support this expansion, hospital chains are employing various strategies. An official from a Gurugram-based hospital chain, speaking to Business Standard, explained, "This progress was supported by initiatives to strengthen brand visibility and enhance digital and online engagement." These initiatives include setting up international patient offices, forging partnerships with local doctors and healthcare providers in target countries, conducting medical camps, and leveraging digital marketing and telemedicine platforms to reach prospective patients. Aster DM Healthcare, for example, saw its MVT revenues within Kerala grow by 51% with "stronger inflows from Maldives helping offset macro-related softness from West Asia, demonstrating the resilience and diversification of the platform," as stated by Alisha Moopen, Deputy Managing Director at Aster DM Healthcare.
These proactive steps have proven instrumental in offsetting the softness from the two major traditional markets, showcasing the industry’s dynamic ability to adapt and seek out new avenues for growth.
Infrastructure and Capacity Enhancement
To cater to the increasing demand for high-end procedures and to attract a more discerning international clientele, Indian hospitals have also continued to invest heavily in their infrastructure and technological capabilities. The Max Healthcare spokesperson’s mention of "improved capacity utilisation and its new and modern infrastructure" is indicative of a broader industry trend. This includes upgrading operation theatres with robotic surgery platforms, investing in advanced diagnostic imaging equipment, expanding intensive care units, and creating dedicated international patient wings that offer enhanced comfort and personalized services. These investments are not just about capacity but also about signaling a commitment to world-class care, which is a significant draw for medical tourists.
Key Players and Their Performance
The performance of individual hospital chains provides granular insight into the sector’s overall trajectory and the effectiveness of their respective strategies.
Fortis Healthcare: Navigating Challenges to Record Growth
Fortis Healthcare’s financial performance in FY26 stands out as a testament to strategic resilience. Despite the initial dip in patient flow due to the West Asia conflict, the group managed to achieve an 18.5% Y-o-Y rise in MVT revenues, reaching ₹639 crore. This was achieved by effectively managing existing patients and, crucially, by diversifying its patient source countries. The focus on regions like Iraq, Uzbekistan, Kenya, Tanzania, Ethiopia, and Uganda demonstrates a successful geographical reorientation that mitigated risks from traditional markets.
Max Healthcare: Resilience Through Strategic Focus
Max Healthcare’s robust year-on-year growth in international patient revenues in FY26 was primarily driven by its strategic focus on complex, high-end tertiary and quaternary care. Their emphasis on oncology, transplants, and robotic surgeries, coupled with investments in modern infrastructure and improved capacity utilization, allowed them to command higher realisations. The company spokesperson highlighted that "while the ongoing West Asia crisis has led to a decline in patient volumes from the region, the company’s overall growth remains resilient due to strong traction across emerging markets in the CIS, Africa and Southeast Asia." This reinforces the critical role of market diversification in maintaining growth amidst regional instabilities.
Apollo Hospitals: Adapting to Market Shifts
Apollo Hospitals, a pioneer in India’s private healthcare sector, also navigated the challenging landscape successfully. Managing Director Suneeta Reddy’s comments during an earnings call, acknowledging lower seasonal medical admissions and moderation in international patient volumes (especially from Bangladesh), yet affirming strong FY26 performance, indicates a successful adaptation. Apollo’s strategy involved increasing its share of patients from Africa, West Asia, and Southeast Asia, effectively offsetting the dip from its historically dominant Bangladeshi market. This demonstrates the agility required to pivot and capture growth opportunities in new or less-explored markets.
Aster DM Healthcare: Regional Strengths and Diversification
Aster DM Healthcare showcased exceptional growth, with its MVT segment growing 41% Y-o-Y. A notable aspect of their performance was the 51% growth in MVT revenues within Kerala, driven by stronger inflows from the Maldives. Alisha Moopen, Deputy Managing Director, emphasized how the Maldives’ contribution helped "offset macro-related softness from West Asia, demonstrating the resilience and diversification of the platform." This highlights the importance of leveraging regional strengths and exploring niche markets that might be less affected by broader geopolitical currents.
Medanta: Long-Term Optimism
Medanta, another significant player, also reported strong growth in its international business. Pankaj Prakash Sahni, the company’s Group Chief Executive Officer and Director, expressed a broader optimism regarding the long-term outlook. Addressing Medanta’s earnings call, he stated that the challenges in West Asia would eventually taper off, adding confidently that Bangladesh, as an international market, would return eventually. This perspective reflects a belief in the fundamental strengths of India’s MVT sector and the enduring need for quality, affordable healthcare that transcends temporary political and geographical disruptions.
The Broader Landscape of India’s MVT Sector
The performance in FY26 is not just a story of individual hospital successes but also a testament to the robust foundation of India’s medical value tourism sector.
India’s Competitive Edge in Medical Tourism
India’s competitive advantages are multifaceted. Beyond the significant cost savings (often a fraction of prices in the US or Europe), the country boasts a vast pool of highly skilled and English-speaking medical professionals, many of whom are trained internationally. Leading hospitals hold international accreditations like JCI (Joint Commission International), ensuring global standards of quality and patient safety. The availability of advanced medical technology, a wide spectrum of treatment options, and a cultural ethos of hospitality further enhance India’s appeal. Furthermore, the ease of obtaining medical visas, combined with well-developed infrastructure in major cities, makes the overall patient journey relatively smooth.
Government Support and Regulatory Framework
The Indian government has also recognized the immense potential of MVT and has been actively promoting it through various initiatives. Programs like the "Heal in India" campaign aim to streamline the process for international patients, improve infrastructure, and promote India as a global healthcare destination. Simplification of visa procedures for medical tourists and the establishment of dedicated international patient desks in hospitals are part of these efforts. Such governmental support provides a crucial enabling environment for the sector’s growth and resilience.
Economic Multiplier Effect
The growth of the MVT sector has a significant multiplier effect on the broader Indian economy. It boosts allied industries such as hospitality (hotels, guesthouses), travel and transport (airlines, taxis), pharmaceuticals, medical equipment suppliers, and even local retail and tourism. This creates numerous job opportunities, from highly skilled medical professionals to support staff, drivers, and translators, contributing substantially to national income and foreign exchange earnings.
Outlook for FY27: Cautious Optimism Amidst Evolving Dynamics
Looking ahead to FY27, Indian hospitals remain cautiously optimistic about international patient revenue growth. While geopolitical uncertainties in key West Asian markets may continue to affect short-term performance, the industry is poised to build on the strategic shifts initiated in FY26.
Geopolitical Stability: A Key Determinant
The return to full momentum in the MVT sector is heavily contingent on the geopolitical stability in key markets. The ongoing West Asia crisis remains a critical factor, and its resolution or de-escalation would significantly ease travel and patient flow. Hospitals are proactively monitoring the situation and developing contingency plans. Some hospital companies have noted that while the current flow of international patients from West Asia hasn’t seen a significant impact, the number of new registrations from the region might decline if the conflict persists, underscoring the need for sustained peace.
Continued Market Penetration and Partnerships
The strategy of market diversification and penetration into new geographies will continue to be a cornerstone for FY27. Anil Vinayak of Fortis Healthcare expressed this sentiment clearly: "With improving market penetration, enhanced regional partnerships, and continued focus on patient acquisition, the international business is expected to regain momentum during FY27, subject to geopolitical stability in key markets." This involves deepening existing relationships in emerging markets, exploring new avenues, and leveraging digital platforms for broader outreach and patient engagement.
A Max spokesperson echoed this sentiment, stating that while the ongoing West Asia crisis has led to a decline in patient volumes from the region, the company’s "overall growth remains resilient due to strong traction across emerging markets in the CIS, Africa and Southeast Asia." This indicates a continued focus on these new growth drivers to maintain a robust international patient base.
The Future of Medical Value Tourism
The future of medical value tourism in India is likely to be characterized by several evolving trends. Telemedicine and digital health platforms, which gained prominence during the pandemic, will continue to play a crucial role in pre-consultations, post-operative follow-ups, and building trust with international patients. There will be an increasing focus on personalized care, niche specializations, and integrating traditional Indian wellness practices with modern medicine.
India’s MVT sector has proven its ability to adapt and thrive amidst adversity. By strategically focusing on high-value procedures, diversifying its patient base, and investing in advanced infrastructure and digital engagement, Indian hospitals are not just surviving but excelling. The lessons learned from FY26 will undoubtedly strengthen India’s position as a resilient and premier global destination for medical value tourism, poised for sustained growth in the years to come.
